Searching for novel targets in IO with the co-founder and CEO of Cartography Biosciences

Stifel's Paul Matteis covers earnings season and recent clinical data in biotech on Analyst Thursdays

Atomic AI's founder on deriving the three-dimensional structure of RNA molecules and leveraging the result for drug discovery

As biotech gravitates to machine learning and AI, insitro's founder shares her experience of working this way since 2018

Wedbush analyst David Nierengarten joins BiotechTV for Analyst Thursdays from San Francisco

The co-founder of Scion Life Sciences on coming out of stealth mode and the new $310 million venture fund announced this week

Louis Kassa, an expert in the region, gives an overview of the Pennsylvania biopharma ecosystem

Children's Hospital of Philadelphia's Stephan Grupp on the sickle cell launches and the latest in CAR-T

Bruce Levine on UPenn's Center for Cellular Immunotherapies and his thoughts regarding FDA's recent CAR-T guidance

An overview of Philly biotech and the success of Spark with Jeff Marrazzo

Five Questions with Xencor CEO Bassil Dahiyat

Deutsche Bank's Neena Bitritto-Garg joins Analyst Thursdays to highlight the CNS space and more

Mizuho analyst Salim Syed joins Analyst Thursdays to talk about this week’s news from Cytokinetics, Gilead, and more

Stifel's Tim Opler shares feedback from SF Healthcare Week and thoughts on biotech's year ahead from a banking perspective

Eric Schmidt on joining Cantor Fitzgerald and his thoughts on the year ahead

How NYSE is investing in the biotech sector

Jefferies analyst Michael Yee previews the year ahead, the outlook for M&A, and dives into top picks

SF Healthcare Week: A buy side perspective of biotech with Affinity's Patrick Nosker

Flagship Pioneering's Noubar Afeyan's take on biotech heading into 2024

SF Healthcare Week: Baird's Brian Skorney gives his take on Monday morning's conference news